Additionally, it has been shown that other IDHmut cancers, such as cholangiocarcinomas and colorectal cancers, have also exhibited enhanced sensitivity to BET inhibitors (Fujiwara et al. 2018; McCleland et al. 2016). The gene discussed is DNER; the disease is cancer.